BCL2 and cancer: Apoptosis via the intrinsic mitochondrial pathway, characterized by increased B-cell lymphoma-2-associated X protein (BAX), reduced B-cell lymphoma-2 (BCL-2), and activation of caspase-3, is a widely recognized mechanism of effective anti-cancer agents (8, 9).